BPAX Price to Book Ratio is 4.14 The company has in Phase III LibiGel ® Efficacy Results, Cancer Vaccines: Chronic Myeloid Leukemia CML in Phase II clinical trial, Acute Myeloid Leukemia (AML) in Phase II and Phase II Pancreatic Cancer in, The Pill-Plus ™ is an oral Currently in Development contraceptive in Phase II. Finally someone that knows what they're talking about and knows the biotech industry that has actually done their dd and researchhttp://seekingalpha.com/instablog/1342291-mr-traderusa/321191-3-biotech-stocks-undervalued